6 Results for "

K562 chronic myelogenous leukemia cell

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "K562 chronic myelogenous leukemia cell" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-125771
CAS No.: 19420-57-6
Purity:  99.53%
Synonyms: 18:0 Lyso-PC; LPC(18:0)
1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells .
loading...
    loading...
Cat. No.: HY-103274
CAS No.: 287204-45-9
Purity:  99.27%
Target:  

Bcr-Abl Src c-Kit Apoptosis

Research Areas:  

Neurological Disease Cancer

PD180970 is a highly potent and ATP-competitive p210 Bcr-Abl kinase inhibitor, with an IC50 of 5 nM for inhibiting the autophosphorylation of p210 Bcr-Abl. PD180970 also inhibits Src and KIT kinase with IC50s of 0.8 nM and 50 nM, respectively. PD180970 indcues apoptosis of K562 leukemic cells, and can be used for chronic myelogenous leukemia research .
loading...
    loading...
Cat. No.: HY-125771S
CAS No.: 327178-92-7
Synonyms: 18:0 Lyso-PC-d35; LPC(18:0)-d35
1-Stearoyl-sn-glycero-3-phosphocholine-d35 is deuterium labeled 1-Stearoyl-sn-glycero-3-phosphocholine (HY-125771). 1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells .
loading...
    loading...
Cat. No.: HY-149805
CAS No.: 887349-03-3
Target:  

Apoptosis

Research Areas:  

Cancer

Anticancer agent 110 is an anticancer agent with in vitro anticancer activity and excellent anti-leukemia potency. Anticancer agent 110 is highly cytotoxic to K-562 lineage chronic myelogenous leukemia cells at nanomolar concentrations. Anticancer agent 110 causes DNA damage and leads to apoptosis .
loading...
    loading...
Cat. No.: HY-169608
CAS No.: 2362-25-6
Target:  

Bcr-Abl

Research Areas:  

Cancer

BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells) .
loading...
    loading...
Cat. No.: HY-125322
CAS No.: 144860-69-5
Target:  

Bacterial

Research Areas:  

Infection

Reveromycin C is a polyketide originally isolated from Streptomyces that has antifungal activity against C. albicans (MICs=2.0 and >500 μg/mL at pH 3 and 7.4, respectively). Reveromycin C inhibits EGF-induced mitogenic activity in the Balb/MK mouse epidermal cell line. It also reverses the morphology of sarcoma-virus-transformed NRK rat kidney cells (EC50=1.58 μg/mL) and inhibits proliferation of KB cells and K562 human chronic myelogenous leukemia cells (IC50=2.0 μg/mL for both).
loading...
    loading...